-
Je něco špatně v tomto záznamu ?
Characterization of Additive Gene-environment Interactions For Colorectal Cancer Risk
CE. Thomas, Y. Lin, M. Kim, ES. Kawaguchi, C. Qu, CY. Um, BM. Lynch, B. Van Guelpen, K. Tsilidis, R. Carreras-Torres, FJB. van Duijnhoven, LC. Sakoda, PT. Campbell, Y. Tian, J. Chang-Claude, S. Bézieau, A. Budiarto, JR. Palmer, PA. Newcomb, G....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
Grantová podpora
001
World Health Organization - International
- MeSH
- dieta MeSH
- dospělí MeSH
- genetická predispozice k nemoci * MeSH
- index tělesné hmotnosti MeSH
- interakce genů a prostředí * MeSH
- jednonukleotidový polymorfismus MeSH
- kolorektální nádory * genetika epidemiologie MeSH
- kouření škodlivé účinky MeSH
- lidé středního věku MeSH
- lidé MeSH
- logistické modely MeSH
- pití alkoholu MeSH
- rizikové faktory MeSH
- senioři MeSH
- studie případů a kontrol MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Colorectal cancer (CRC) is a common, fatal cancer. Identifying subgroups who may benefit more from intervention is of critical public health importance. Previous studies have assessed multiplicative interaction between genetic risk scores and environmental factors, but few have assessed additive interaction, the relevant public health measure. METHODS: Using resources from CRC consortia, including 45,247 CRC cases and 52,671 controls, we assessed multiplicative and additive interaction (relative excess risk due to interaction, RERI) using logistic regression between 13 harmonized environmental factors and genetic risk score, including 141 variants associated with CRC risk. RESULTS: There was no evidence of multiplicative interaction between environmental factors and genetic risk score. There was additive interaction where, for individuals with high genetic susceptibility, either heavy drinking (RERI = 0.24, 95% confidence interval [CI] = 0.13, 0.36), ever smoking (0.11 [0.05, 0.16]), high body mass index (female 0.09 [0.05, 0.13], male 0.10 [0.05, 0.14]), or high red meat intake (highest versus lowest quartile 0.18 [0.09, 0.27]) was associated with excess CRC risk greater than that for individuals with average genetic susceptibility. Conversely, we estimate those with high genetic susceptibility may benefit more from reducing CRC risk with aspirin/nonsteroidal anti-inflammatory drugs use (-0.16 [-0.20, -0.11]) or higher intake of fruit, fiber, or calcium (highest quartile versus lowest quartile -0.12 [-0.18, -0.050]; -0.16 [-0.23, -0.09]; -0.11 [-0.18, -0.05], respectively) than those with average genetic susceptibility. CONCLUSIONS: Additive interaction is important to assess for identifying subgroups who may benefit from intervention. The subgroups identified in this study may help inform precision CRC prevention.
Bioinformatics and Data Science Research Center Bina Nusantara University Jakarta Indonesia
Broad Institute of Harvard and MIT Cambridge MA
Broad Institute of MIT and Harvard Cambridge MA
Cancer Epidemiology Division Cancer Council Victoria Melbourne Victoria Australia
Center for Cancer Research Medical University of Vienna Vienna Austria
Center for Gastrointestinal Biology and Disease University of North Carolina Chapel Hill NC
Center for Public Health Genomics University of Virginia Charlottesville VA
Computer Science Department School of Computer Science Bina Nusantara University Jakarta Indonesia
Consortium for Biomedical Research in Epidemiology and Public Health Madrid Spain
Department of Biostatistics University of Washington Seattle WA
Department of Cancer Medicine The University of Texas MD Anderson Cancer Center Houston TX
Department of Computer Science Stanford University Stanford CA
Department of Epidemiology and Population Health Albert Einstein College of Medicine Bronx NY
Department of Epidemiology Harvard T H Chan School of Public Health Harvard University Boston MA
Department of Epidemiology Johns Hopkins Bloomberg School of Public Health Baltimore MD
Department of Epidemiology University of Washington School of Public Health Seattle WA
Department of Epidemiology University of Washington Seattle WA
Department of Family Medicine University of Virginia Charlottesville VA
Department of Genetics Stanford University Stanford CA
Department of Hygiene and Epidemiology University of Ioannina School of Medicine Ioannina Greece
Department of Medical Oncology Dana Farber Cancer Institute Boston MA
Department of Medicine Brigham and Women's Hospital Harvard Medical School Boston MA
Department of Nutrition Harvard T H Chan School of Public Health Harvard University Boston MA
Department of Nutritional Sciences University of Michigan School of Public Health Ann Arbor MI
Department of Population Health Sciences University of Utah Salt Lake City UT
Department of Population Science American Cancer Society Atlanta GA
Department of Radiation Sciences Oncology Unit Umeå University Umeå Sweden
Departments of Epidemiology and Nutrition Harvard TH Chan School of Public Health Boston MA
Departments of Medicine and Epidemiology University of Pittsburgh Medical Center Pittsburgh PA
Digestive Diseases and Microbiota Group Girona Biomedical Research Institute Salt Girona Spain
Division of Cancer Epidemiology German Cancer Research Center Heidelberg Germany
Division of Gastroenterology Massachusetts General Hospital and Harvard Medical School Boston MA
Division of Human Nutrition and Health Wageningen University and Research Wageningen The Netherlands
Division of Preventive Oncology German Cancer Research Center Heidelberg Germany
Division of Research Kaiser Permanente Northern California Oakland CA
Faculty of Medicine and Biomedical Center in Pilsen Charles University Pilsen Czech Republic
From the Public Health Sciences Division Fred Hutchinson Cancer Center Seattle WA
German Cancer Consortium Heidelberg Germany
Harvard TH Chan School of Public Health
Huntsman Cancer Institute Salt Lake City UT
Institute for Health Research Kaiser Permanente Colorado Aurora CO
Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden
Leeds Institute of Medical Research University of Leeds Leeds UK
Memorial University of Newfoundland Discipline of Genetics St John's Canada
Norris Comprehensive Cancer Center University of Southern California Los Angeles CA
Nutrition and Metabolism Branch International Agency for Research on Cancer Lyon France
ONCOBELL Program Bellvitge Biomedical Research Institute L'Hospitalet de Llobregat Barcelona Spain
School of Public Health Capital Medical University Beijing China
Service de Génétique Médicale Centre Hospitalier Universitaire Nantes Nantes France
Slone Epidemiology Center at Boston University Boston MA
SWOG Statistical Center Fred Hutchinson Cancer Center Seattle WA
Unit of Biomarkers and Suceptibility L'Hospitalet del Llobregat Barcelona Spain
University Medical Centre Hamburg Eppendorf University Cancer Centre Hamburg Hamburg Germany
University of Hawaii Cancer Center Honolulu HI
University of Southern California Department of Population and Public Health Sciences Los Angeles CA
Wallenberg Centre for Molecular Medicine Umeå University Umeå Sweden
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25002922
- 003
- CZ-PrNML
- 005
- 20250206103941.0
- 007
- ta
- 008
- 250121s2025 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/EDE.0000000000001795 $2 doi
- 035 __
- $a (PubMed)39316822
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Thomas, Claire E $u From the Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA $1 https://orcid.org/0000000195153277
- 245 10
- $a Characterization of Additive Gene-environment Interactions For Colorectal Cancer Risk / $c CE. Thomas, Y. Lin, M. Kim, ES. Kawaguchi, C. Qu, CY. Um, BM. Lynch, B. Van Guelpen, K. Tsilidis, R. Carreras-Torres, FJB. van Duijnhoven, LC. Sakoda, PT. Campbell, Y. Tian, J. Chang-Claude, S. Bézieau, A. Budiarto, JR. Palmer, PA. Newcomb, G. Casey, L. Le Marchandz, M. Giannakis, CI. Li, A. Gsur, C. Newton, M. Obón-Santacana, V. Moreno, P. Vodicka, H. Brenner, M. Hoffmeister, AJ. Pellatt, RE. Schoen, N. Dimou, N. Murphy, MJ. Gunter, S. Castellví-Bel, JC. Figueiredo, AT. Chan, M. Song, L. Li, DT. Bishop, SB. Gruber, JW. Baurley, SA. Bien, DV. Conti, JR. Huyghe, A. Kundaje, YR. Su, J. Wang, TO. Keku, MO. Woods, SI. Berndt, SJ. Chanock, CM. Tangen, A. Wolk, A. Burnett-Hartman, AH. Wu, E. White, MA. Devall, V. Díez-Obrero, DA. Drew, E. Giovannucci, A. Hidaka, AE. Kim, JP. Lewinger, J. Morrison, J. Ose, N. Papadimitriou, B. Pardamean, AR. Peoples, EA. Ruiz-Narvaez, A. Shcherbina, MC. Stern, X. Chen, DC. Thomas, EA. Platz, WJ. Gauderman, U. Peters, L. Hsu
- 520 9_
- $a BACKGROUND: Colorectal cancer (CRC) is a common, fatal cancer. Identifying subgroups who may benefit more from intervention is of critical public health importance. Previous studies have assessed multiplicative interaction between genetic risk scores and environmental factors, but few have assessed additive interaction, the relevant public health measure. METHODS: Using resources from CRC consortia, including 45,247 CRC cases and 52,671 controls, we assessed multiplicative and additive interaction (relative excess risk due to interaction, RERI) using logistic regression between 13 harmonized environmental factors and genetic risk score, including 141 variants associated with CRC risk. RESULTS: There was no evidence of multiplicative interaction between environmental factors and genetic risk score. There was additive interaction where, for individuals with high genetic susceptibility, either heavy drinking (RERI = 0.24, 95% confidence interval [CI] = 0.13, 0.36), ever smoking (0.11 [0.05, 0.16]), high body mass index (female 0.09 [0.05, 0.13], male 0.10 [0.05, 0.14]), or high red meat intake (highest versus lowest quartile 0.18 [0.09, 0.27]) was associated with excess CRC risk greater than that for individuals with average genetic susceptibility. Conversely, we estimate those with high genetic susceptibility may benefit more from reducing CRC risk with aspirin/nonsteroidal anti-inflammatory drugs use (-0.16 [-0.20, -0.11]) or higher intake of fruit, fiber, or calcium (highest quartile versus lowest quartile -0.12 [-0.18, -0.050]; -0.16 [-0.23, -0.09]; -0.11 [-0.18, -0.05], respectively) than those with average genetic susceptibility. CONCLUSIONS: Additive interaction is important to assess for identifying subgroups who may benefit from intervention. The subgroups identified in this study may help inform precision CRC prevention.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a kolorektální nádory $x genetika $x epidemiologie $7 D015179
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a interakce genů a prostředí $7 D059647
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a logistické modely $7 D016015
- 650 _2
- $a pití alkoholu $7 D000428
- 650 _2
- $a kouření $x škodlivé účinky $7 D012907
- 650 _2
- $a index tělesné hmotnosti $7 D015992
- 650 _2
- $a jednonukleotidový polymorfismus $7 D020641
- 650 _2
- $a dieta $7 D004032
- 650 _2
- $a dospělí $7 D000328
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Lin, Yi $u From the Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA
- 700 1_
- $a Kim, Michelle $u From the Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA
- 700 1_
- $a Kawaguchi, Eric S $u Division of Biostatistics, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA
- 700 1_
- $a Qu, Conghui $u From the Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA
- 700 1_
- $a Um, Caroline Y $u Department of Population Science, American Cancer Society, Atlanta, GA
- 700 1_
- $a Lynch, Brigid M $u Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia $u Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Victoria, Australia
- 700 1_
- $a Van Guelpen, Bethany $u Department of Radiation Sciences, Oncology Unit, Umeå University, Umeå, Sweden $u Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, Sweden
- 700 1_
- $a Tsilidis, Kostas $u Department of Epidemiology and Biostatistics, Imperial College London, School of Public Health, London, UK $u Department of Hygiene and Epidemiology, University of Ioannina, School of Medicine, Ioannina, Greece
- 700 1_
- $a Carreras-Torres, Robert $u Colorectal Cancer Group, ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain $u Digestive Diseases and Microbiota Group, Girona Biomedical Research Institute (IDIBGI), Salt, Girona, Spain
- 700 1_
- $a van Duijnhoven, Franzel J B $u Division of Human Nutrition and Health, Wageningen University & Research, Wageningen, The Netherlands
- 700 1_
- $a Sakoda, Lori C $u From the Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA $u Division of Research, Kaiser Permanente Northern California, Oakland, CA
- 700 1_
- $a Campbell, Peter T $u Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY
- 700 1_
- $a Tian, Yu $u Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany $u School of Public Health, Capital Medical University, Beijing, China
- 700 1_
- $a Chang-Claude, Jenny $u Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany $u University Medical Centre Hamburg-Eppendorf, University Cancer Centre Hamburg (UCCH), Hamburg, Germany
- 700 1_
- $a Bézieau, Stéphane $u Service de Génétique Médicale, Centre Hospitalier Universitaire (CHU) Nantes, Nantes, France
- 700 1_
- $a Budiarto, Arif $u Bioinformatics and Data Science Research Center, Bina Nusantara University, Jakarta, Indonesia $u Computer Science Department, School of Computer Science, Bina Nusantara University, Jakarta, Indonesia
- 700 1_
- $a Palmer, Julie R $u Slone Epidemiology Center at Boston University, Boston, MA
- 700 1_
- $a Newcomb, Polly A $u From the Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA $u Department of Epidemiology, University of Washington, Seattle, WA
- 700 1_
- $a Casey, Graham $u Center for Public Health Genomics, University of Virginia, Charlottesville, VA
- 700 1_
- $a Le Marchandz, Loic $u University of Hawaii Cancer Center, Honolulu, HI
- 700 1_
- $a Giannakis, Marios $u Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA $u Broad Institute of MIT and Harvard, Cambridge, MA $u Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
- 700 1_
- $a Li, Christopher I $u From the Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA
- 700 1_
- $a Gsur, Andrea $u Center for Cancer Research, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Newton, Christina $u Department of Population Science, American Cancer Society, Atlanta, GA
- 700 1_
- $a Obón-Santacana, Mireia $u Unit of Biomarkers and Suceptibility (UBS), Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain $u ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain $u Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain
- 700 1_
- $a Moreno, Victor $u Unit of Biomarkers and Suceptibility (UBS), Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain $u ONCOBELL Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain $u Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain $u Department of Clinical Sciences, Faculty of Medicine and health Sciences and Universitat de Barcelona Institute of Complex Systems (UBICS), University of Barcelona (UB), L'Hospitalet de Llobregat, Barcelona, Spain
- 700 1_
- $a Vodicka, Pavel $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Prague, Czech Republic $u Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague, Czech Republic $u Faculty of Medicine and Biomedical Center in Pilsen, Charles University, Pilsen, Czech Republic
- 700 1_
- $a Brenner, Hermann $u Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany $u Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany $u German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany
- 700 1_
- $a Hoffmeister, Michael $u Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany
- 700 1_
- $a Pellatt, Andrew J $u Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
- 700 1_
- $a Schoen, Robert E $u Departments of Medicine and Epidemiology, University of Pittsburgh Medical Center, Pittsburgh, PA
- 700 1_
- $a Dimou, Niki $u Nutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France
- 700 1_
- $a Murphy, Neil $u Nutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France
- 700 1_
- $a Gunter, Marc J $u Nutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France
- 700 1_
- $a Castellví-Bel, Sergi $u Gastroenterology Department, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), University of Barcelona, Barcelona, Spain
- 700 1_
- $a Figueiredo, Jane C $u Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA $u Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA
- 700 1_
- $a Chan, Andrew T $u Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA $u Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA $u Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA $u Broad Institute of Harvard and MIT, Cambridge, MA $u Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA $u Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA
- 700 1_
- $a Song, Mingyang $u Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA $u Departments of Epidemiology and Nutrition, Harvard TH Chan School of Public Health, Boston, MA $u Department of Nutrition, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA
- 700 1_
- $a Li, Li $u Department of Family Medicine, University of Virginia, Charlottesville, VA
- 700 1_
- $a Bishop, D Timothy $u Leeds Institute of Medical Research, University of Leeds, Leeds, UK
- 700 1_
- $a Gruber, Stephen B $u Department of Medical Oncology & Therapeutics Research, City of Hope National Medical Center, Duarte CA
- 700 1_
- $a Baurley, James W $u Bioinformatics and Data Science Research Center, Bina Nusantara University, Jakarta, Indonesia $u BioRealm LLC, Walnut, CA
- 700 1_
- $a Bien, Stephanie A $u From the Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA
- 700 1_
- $a Conti, David V $u Division of Biostatistics, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA
- 700 1_
- $a Huyghe, Jeroen R $u From the Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA
- 700 1_
- $a Kundaje, Anshul $u Department of Genetics, Stanford University, Stanford, CA $u Department of Computer Science, Stanford University, Stanford, CA
- 700 1_
- $a Su, Yu-Ru $u From the Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA
- 700 1_
- $a Wang, Jun $u Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA $u Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA
- 700 1_
- $a Keku, Temitope O $u Center for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, NC
- 700 1_
- $a Woods, Michael O $u Memorial University of Newfoundland, Discipline of Genetics, St. John's, Canada
- 700 1_
- $a Berndt, Sonja I $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD
- 700 1_
- $a Chanock, Stephen J $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD
- 700 1_
- $a Tangen, Catherine M $u SWOG Statistical Center, Fred Hutchinson Cancer Center, Seattle, WA
- 700 1_
- $a Wolk, Alicja $u Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
- 700 1_
- $a Burnett-Hartman, Andrea $u Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO
- 700 1_
- $a Wu, Anna H $u University of Southern California, Department of Population and Public Health Sciences, Los Angeles, CA
- 700 1_
- $a White, Emily $u From the Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA $u Department of Epidemiology, University of Washington School of Public Health, Seattle, WA
- 700 1_
- $a Devall, Matthew A $u Department of Family Medicine, University of Virginia, Charlottesville, VA
- 700 1_
- $a Díez-Obrero, Virginia $u Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
- 700 1_
- $a Drew, David A $u Clinical & Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA
- 700 1_
- $a Giovannucci, Edward $u Harvard TH Chan School of Public Health $u Department of Biostatistics, University of Washington, Seattle, WA
- 700 1_
- $a Hidaka, Akihisa $u From the Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA
- 700 1_
- $a Kim, Andre E $u Division of Biostatistics, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA
- 700 1_
- $a Lewinger, Juan Pablo $u Division of Biostatistics, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA
- 700 1_
- $a Morrison, John $u Division of Biostatistics, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA
- 700 1_
- $a Ose, Jennifer $u Huntsman Cancer Institute, Salt Lake City, UT $u Department of Population Health Sciences, University of Utah, Salt Lake City, UT
- 700 1_
- $a Papadimitriou, Nikos $u Nutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France
- 700 1_
- $a Pardamean, Bens $u Bioinformatics and Data Science Research Center, Bina Nusantara University, Jakarta, Indonesia
- 700 1_
- $a Peoples, Anita R $u Huntsman Cancer Institute, Salt Lake City, UT $u Department of Population Health Sciences, University of Utah, Salt Lake City, UT
- 700 1_
- $a Ruiz-Narvaez, Edward A $u Department of Nutritional Sciences, University of Michigan School of Public Health, Ann Arbor, MI
- 700 1_
- $a Shcherbina, Anna $u Department of Genetics, Stanford University, Stanford, CA $u Department of Computer Science, Stanford University, Stanford, CA
- 700 1_
- $a Stern, Mariana C $u Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA
- 700 1_
- $a Chen, Xuechen $u Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany
- 700 1_
- $a Thomas, Duncan C $u Division of Biostatistics, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA
- 700 1_
- $a Platz, Elizabeth A $u Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
- 700 1_
- $a Gauderman, W James $u Division of Biostatistics, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA
- 700 1_
- $a Peters, Ulrike $u From the Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA $u Department of Epidemiology, University of Washington, Seattle, WA
- 700 1_
- $a Hsu, Li $u From the Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA $u Department of Biostatistics, University of Washington, Seattle, WA $1 https://orcid.org/0000000181684712
- 773 0_
- $w MED00004963 $t Epidemiology $x 1531-5487 $g Roč. 36, č. 1 (2025), s. 126-138
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39316822 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206103936 $b ABA008
- 999 __
- $a ok $b bmc $g 2262986 $s 1238929
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 36 $c 1 $d 126-138 $e 20240924 $i 1531-5487 $m Epidemiology $n Epidemiology $x MED00004963
- GRA __
- $a 001 $p World Health Organization $2 International
- LZP __
- $a Pubmed-20250121
